Adam H. Schechter

Adam H. Schechter (48) has served as a director of the Laboratory Corporation of America since April 1, 2013.

Mr. Schechter is an Executive Vice President of Merck & Co., Inc. and the President of Merck's Global Human Health Division since 2010, which includes the company's worldwide pharmaceutical and vaccine businesses. He is a member of Merck's executive committee and pharmaceutical and vaccines operating committee. Prior to becoming President, Global Human Health, Mr. Schechter served as President, Global Pharmaceutical Business from 2007 to 2010. Mr. Schechter's extensive experience at Merck includes global and U.S.-focused leadership roles spanning sales, marketing, and managed markets, as well as business and product development.

Mr. Schechter serves on the board of directors for the European Federation of Pharmaceutical Industries and Associations.

He is a Board Member for Water.org and an Executive Board Member for the National Alliance for Hispanic Health. Mr. Schechter brings to the Board global business acumen and general management experience, as well as demonstrated success in leading large, innovation-focused organizations. Mr. Schechter's deep knowledge of the pharmaceutical and healthcare industries and extensive experience collaborating with many of its key stakeholders to achieve patient-focused outcomes brings practical insight to the business strategies to service the changing healthcare environment.

Adam H. Schechter is the Chairman and CEO at LabCorp, based in United States, North America. With a background in Biotechnology, Adam H. Schechter has a rich history of leadership and innovation.Adam H. Schechter studied unknown Biology at La Salle University. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.